Fungal infections complicating tumor necrosis factor alpha blockade therapy.
about
Antibiotic treatment of animals infected with Borrelia burgdorferiImmunotoxicity of monoclonal antibodiesHistoplasma capsulatum, lung infection and immunityMucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapyA Clinician's Guide to the Diagnosis and Treatment of Candidiasis in Patients with PsoriasisNeutrophils mediate maturation and efflux of lung dendritic cells in response to Aspergillus fumigatus germ tubes.Neutropenia enhances lung dendritic cell recruitment in response to Aspergillus via a cytokine-to-chemokine amplification loopInnate immunity to Aspergillus species.Biologics in dermatologic therapy - an update.Histoplasmosis infection in patients with rheumatoid arthritis, 1998-2009Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease.Pulmonary manifestations of inflammatory bowel diseasePulmonary manifestations of Crohn's disease.Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapyBiologic response modifiers to decrease inflammation: Focus on infection risks.Both anti-TNF and CTLA4 Ig treatments attenuate the disease severity of staphylococcal dermatitis in mice.Histoplasmosis complicating tumor necrosis factor-α blocker therapy: a retrospective analysis of 98 casesAspergillus-associated airway disease, inflammation, and the innate immune responseDisruption of Early Tumor Necrosis Factor Alpha Signaling Prevents Classical Activation of Dendritic Cells in Lung-Associated Lymph Nodes and Development of Protective Immunity against Cryptococcal Infection.Harms of TNF inhibitors in rheumatic diseases: a focused review of the literature.Biological targets in the treatment of rheumatoid arthritis: a comprehensive review of current and in-development biological disease modifying anti-rheumatic drugs.Disseminated Cryptococcosis in a 63-year-old Patient with Multiple Sclerosis Treated with Fingolimod.Severe candida laryngitis in a patient with rheumatoid arthritis treated with adalimumab.Histoplasmosis in Patients With Cell-Mediated Immunodeficiency: Human Immunodeficiency Virus Infection, Organ Transplantation, and Tumor Necrosis Factor-α Inhibition.In silico modeling of spore inhalation reveals fungal persistence following low dose exposureCutaneous histoplasmosis as a complication after anti-TNF use--Case report.Lymphocutaneous Sporotrichosis during Treatment with Anti-TNF-Alpha Monotherapy.Catheter-Related Acremonium kiliense Fungemia in a Patient with Ulcerative Colitis under Treatment with Infliximab.Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease.Les modificateurs de la réponse biologique pour réduire l’inflammation : pleins feux sur les risques d’infection.Fungal infections in patients with inflammatory bowel disease: a systematic review.Cryptococcosis.Pulmonary aspergillosis after treatment with infliximab in Still's disease and a literature review of Still's disease and pulmonary aspergillosis.TNFα antagonism reveals a gut/lung axis that amplifies regulatory T cells in a pulmonary fungal infection.Fungal Diseases in the 21st Century: The Near and Far Horizons
P2860
Q24650857-CD806730-D302-41E4-B55C-81129EEC7893Q24653374-2FA75D86-B401-4AF2-B73B-152E00E22D6BQ26821996-6DE0584E-B729-4B91-B9A8-4B66D7D62882Q27010562-9DE572F1-601B-4C57-BF35-6213F8D16B0DQ30248908-0655047E-E875-4E89-A2B4-6CA355B93B14Q30424239-B994CEA4-5D14-46DE-914A-6DD767FEC240Q30429766-5CB7871A-5BA3-44EB-8B91-55B69E81A630Q30434628-C06948AD-24F7-4056-91AE-67C3700748A2Q33607620-B30CAB3D-377D-4B3A-B505-884741055A0EQ33909467-EAB3F96B-369D-40CF-8832-3C94BC9EDA06Q34127277-C1560A43-B698-4F3D-A7AE-6A884B172394Q34303009-2BD9B4A5-9964-49C4-B30C-F2FA29968B6FQ34397357-1723E474-DF69-47F6-9E48-60481AF1D8FEQ34413227-9D30E785-5CDC-4168-9548-9D3B6F7E40CBQ35779755-86F7276E-CC5A-4232-8FD6-B5E577D029DCQ36298389-69945014-A859-43EC-87C2-B93C21EC5EAAQ36699795-082F3F65-A13C-4C7F-85A3-B1371229F6D5Q37077782-C9CEBF91-D4A8-4B7F-B5B5-2DC8B8496E6AQ37120228-A86269AD-3EF2-4B08-8BEB-521309E025B8Q37189376-2FEBC228-4C7D-4213-8434-F4A4794FE3F8Q37390458-EF312E76-6A6B-4935-8DE0-7657FD9710C2Q39182269-1F141B5C-6856-4828-B2D0-C624C6314EE9Q39318083-2FE23635-20B6-4F1D-B681-C9CAD46D6E79Q40888727-AB6BEA5C-8572-418D-9337-CEA76DFD0986Q41003122-F70BF3D8-1FBD-4C30-AAEA-8CCADC6E25F7Q41030645-AA029099-A2AA-4ABC-A91D-BF3F3F393770Q41440705-78D10E08-44E1-4B1B-AD89-E28A66D45F9EQ42134910-0A11F758-7F33-480D-A9D4-D79BFF5DBBFCQ43132889-3054CD88-140B-4EB0-84D1-0775411E51F5Q46733182-1D47D788-02AD-4296-BD30-1B9C64A8DCAAQ49906677-69BF208E-61A5-49E9-84C5-1EA953B0003AQ51818572-6B7A1727-EE28-48C2-B480-E468B2C2EAC6Q52587077-24F3562C-D2F1-4613-AB1C-79E3A80832F9Q52723984-C8BD97B7-C7B5-4450-B041-576BD285F11EQ59136608-1BFFCA74-9325-497C-A323-27F8241F5EEC
P2860
Fungal infections complicating tumor necrosis factor alpha blockade therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fungal infections complicating tumor necrosis factor alpha blockade therapy.
@en
Fungal infections complicating tumor necrosis factor alpha blockade therapy.
@nl
type
label
Fungal infections complicating tumor necrosis factor alpha blockade therapy.
@en
Fungal infections complicating tumor necrosis factor alpha blockade therapy.
@nl
prefLabel
Fungal infections complicating tumor necrosis factor alpha blockade therapy.
@en
Fungal infections complicating tumor necrosis factor alpha blockade therapy.
@nl
P2093
P1476
Fungal infections complicating tumor necrosis factor alpha blockade therapy
@en
P2093
Dimitrios P Kontoyiannis
Dimitrios T Boumpas
George Samonis
Sotirios Tsiodras
P304
P407
P577
2008-02-01T00:00:00Z